# RFA RCT for Pancreatic or Bile Duct Cancer

> **NCT02166190** · NA · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 8 (actual)

## Conditions studied

- Unresectable Pancreatic Cancer
- Cholangiocarcinoma Non-resectable

## Interventions

- **PROCEDURE:** Radiofrequency Ablation using EndoHPB Probe
- **PROCEDURE:** Stenting only

## Key facts

- **NCT ID:** NCT02166190
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-06
- **Primary completion:** 2017-05-17
- **Final completion:** 2017-05-17
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Enrollment was feasibly not going to be reached.
- **Last updated:** 2019-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02166190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02166190, "RFA RCT for Pancreatic or Bile Duct Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02166190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*